The number of CD4+ lymphocytes and the CD4+/CD8+ ratio were higher both in the 0.1% and 0.2% PCP treatment groups than in the control group (p < 0.05), and they linearly increased with the dietary supplementation of PCP (p = 0.046; p = 0.025). The gene discussed is CD4; the disease is pneumocystosis.